清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

AI-Assisted Analysis of Clinical Trials to Identify Failed Drugs for Revival via Drug Delivery Technologies

临床试验 医学 药品 重症监护医学 不利影响 药物输送 体内分布 药理学 药物反应 药物发现 临床研究设计 疾病 药物开发 靶向给药 药代动力学 医学物理学 功效 临床研究 随机对照试验 批准的药物 药物试验 文档 梅德林 推论
作者
Nianwu Wang,Rui Zhang,Hong‐Bo Pang
出处
期刊:Molecular Pharmaceutics [American Chemical Society]
卷期号:23 (11): 5476-5488
标识
DOI:10.1021/acs.molpharmaceut.6c00594
摘要

Numerous drug candidates showed great promise in experimental and preclinical investigations but failed in clinical trials. One cause to this problem may be nonspecific drug biodistribution, leading to adverse effects in healthy organs. Drug delivery technologies are developed to overcome this exact problem by navigating drugs more selectively to the disease sites. Therefore, they hold the promise to revive at least some failed drugs. However, it is challenging to identify such candidates revivable by drug delivery: first, there lacks systemic survey and documentation of drug biodistribution in patients during the trials; second, clinical trial results, especially the failed ones, are often reported in unstructured and/or inconsistent language. Here, we harnessed the recent advances in artificial intelligence (AI) agents and large language models (LLMs) to tackle with the second problem. An OpenAI-based framework was developed to systemically analyze terminated trials on ClinicalTrials.gov. This framework integrated structured extraction of clinical trial information, disease-site inference with evaluation based on predefined screening criteria, which is unwanted biodistribution (UB failure) reflected by the difference in the anatomical locations between adverse effects and targeted diseases. We also paired this with the analysis of drug types and physicochemical properties (e.g. molecular weight and hydrophobicity). Using a validation set, the model achieved accuracies of 89.69% for UB failure classification, 91.75% for small molecule drug classification, and 88.66% for hydrophobicity classification. We then applied this analysis to all terminated ClinicalTrials.gov trials, which identified 817 trials possibly failed due to UB, and top ten small molecule drugs likely suitable for our peptide-guided delivery platform. Overall, this study may provide a new direction to apply AI technologies for drug development, and inspire future investigations of clinical reports and public information from the perspective of delivery technology applications.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
sshh123发布了新的文献求助60
6秒前
9秒前
美丽代桃完成签到,获得积分10
9秒前
iman完成签到,获得积分10
14秒前
xun发布了新的文献求助10
14秒前
16秒前
TingtingGZ发布了新的文献求助10
21秒前
李pp关注了科研通微信公众号
23秒前
27秒前
故意的丹萱完成签到,获得积分10
28秒前
30秒前
xun完成签到,获得积分20
33秒前
充电宝的应助被兰斯洛特117采纳,获得10
41秒前
能干的修洁完成签到,获得积分10
45秒前
maomao完成签到,获得积分10
46秒前
WebCasa完成签到,获得积分10
50秒前
52秒前
55秒前
76完成签到 ,获得积分10
57秒前
李pp发布了新的文献求助10
1分钟前
超级向日葵完成签到,获得积分10
1分钟前
1分钟前
英俊的铭的应助被兰斯洛特117采纳,获得10
1分钟前
null的应助被科研通管家采纳,获得10
1分钟前
Criminology34的应助被科研通管家采纳,获得10
1分钟前
1分钟前
1分钟前
我是笨蛋完成签到 ,获得积分10
1分钟前
1分钟前
1分钟前
TingtingGZ发布了新的文献求助10
1分钟前
耍酷的手套完成签到,获得积分10
1分钟前
明亮的小兔子完成签到 ,获得积分10
1分钟前
杰西咔发布了新的文献求助10
2分钟前
淡然的霆完成签到,获得积分10
2分钟前
2分钟前
勤奋的猫咪完成签到 ,获得积分10
2分钟前
共享精神的应助被杰西咔采纳,获得10
2分钟前
2分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8173161
求助须知:如何正确求助?哪些是违规求助? 9565558
关于积分的说明 21780458
捐赠科研通 7767231
什么是DOI,文献DOI怎么找? 3431542
关于科研通互助平台的介绍 2555697
邀请新用户注册赠送积分活动 2476682